Cat. No. | Product name | CAS No. |
DCC2046 |
F1386-0303
Novel potent and selective MAP4K4 inhibitor |
287177-12-2 |
DCC2047 |
F1414-1438
Novel bactericidal, killing Mycobacterium tuberculosis by targeting iron-sulfur protein Rv0338c (IspQ), a putative redox sensor |
691370-15-7 |
DCC2048 |
F1414-1444
Novel bactericidal, killing Mycobacterium tuberculosis by targeting iron-sulfur protein Rv0338c (IspQ), a putative redox sensor |
794552-29-7 |
DCC2049 |
F-15741
Selective, potent inhibitor of the late current mediated by the cardiac isoform of the sodium channel (NaV1.5) |
|
DCC2050 |
F2209-0381
Novel and potent inhibitor of PCAF catalytic domain |
929471-38-5 |
DCC2051 |
F81-1144b
Novel matrix metalloproteinase inhibitor, reducing secretion of very low density lipoprotein-triacylglycerol, lowering TAG levels in serum and the liver, VLDL-TAG secretion, de novo FA synthesis in the liver, and serum levels of insulin and glucose |
306733-22-2 |
DCC2052 |
Fa-613
Novel pyrimidine synthesis inhibitor, exhibiting low micromolar antiviral activity against various influenza A and B virus strains, including the highly pathogenic influenza A strains H5N1 and H7N9, enterovirus A71, respiratory syncytial virus, human rhin |
351001-28-0 |
DCC2053 |
Fa-alkyne
Novel clickable fumarate-competitive chemoproteomic probe |
671188-20-8 |
DCC2054 |
Fabh Inhibitor 10
Novel FabH Inhibitor, showing potent antibacterial activity with a MIC value of 3.89–7.81 μM−1 against the tested bacterial strains and exhibiting potent E. coli FabH inhibitory activity with an IC 50 value of 1.6 μM |
|
DCC2055 |
Fabh-in-44
Novel inhibitor of β-ketoacyl-(acyl-carrier-protein) synthase III (FabH). |
|
DCC2056 |
Fabp4/5-in-3
Novel FABP4/5 inhibitor, inhibiting lipolysis in 3T3-L1 adipocytes and in primary human adipocytes, reducing plasma triglyceride and free fatty acid levels, ameliorating dyslipidemia but not insulin resistance in mice with diet-induced obesity |
|
DCC2057 |
Fabp4/5-in-a16
Novel dual inhibitor of fatty acid binding protein 4 (FABP4) and fatty acid binding protein 5 (FABP5) |
|
DCC2058 |
Fabp4/5-in-b8
Novel dual inhibitor of fatty acid binding protein 4 (FABP4) and fatty acid binding protein 5 (FABP5) |
|
DCC2059 |
Factor Viia Inhibitor 1
Novel factor VIIa inhibitor |
951794-04-0 |
DCC2060 |
Factor Viia Inhibitor 2
Novel factor VIIa inhibitor |
951803-90-0 |
DCC2061 |
Fagaronine Chloride
Novel antileukaemic alkaloid; Inhibitor of reverse transcriptase activity of RNA-tumor viruses; Inhibitor of topoisomerase I |
52259-64-0 |
DCC2062 |
Fa-gflg-sn38
Novel Folate Receptor Targeting and Cathepsin B-Sensitive Drug Delivery System for Selective Cancer Cell Death and Imaging, exhibited strong cytotoxicity against FR-overexpressing SK-Hep-1, HeLa, and Siha cells, with IC50 values of 2-3 μM, but had no effe |
|
DCC2063 |
Fa-hp-ß-cyd
Novel folate-appended 2-hydroxypropyl-ß-cyclodextrin (HP-ß-CyD), showing strong anti-leukemia and cell-binding activities, inhibiting the growth of FR-expressing cells, enterjng CML cells through endocytosis and inducing both apoptosis and autophagy via m |
|
DCC2064 |
Fai-40
Novel inhibitor of fungal fatty acid biosynthesis, demonstrating broad-spectrum activity against Candida auris and mucormycetes and retained the activity against azole-resistant candida isolates |
|
DCC2065 |
Fak Blocker A18
Novel blocker of focal adhesion kinase (FAK) autophosphorylation |
|
DCC2066 |
Fak Degrader Fc-11
Novel highly potent FAK-targeting PROTAC degrader, showing a rapid and reversible FAK degradation |
2271035-37-9 |
DCC2067 |
Fam-deala-hyp-yipd
Novel Fluorescent HIF-1α peptide |